← Back to Search

Moisturizer Routine Monitoring for Eczema

N/A

Waitlist Available

Led By Steven R Feldman, MD, PhD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subject is 18 years of age or older.

Subject with a diagnosis of xerosis in the context (current or historic) of atopic dermatitis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 3 month

Awards & highlights

Study Summary

This trial will test whether measuring a person's skin hydration levels will help them to better follow their moisturizer routine and prevent disease relapse.

Who is the study for?

This trial is for adults over 18 with dry skin (xerosis) related to eczema or atopic dermatitis, who can communicate in English. It's not suitable for those under 18 or without a working knowledge of English.Check my eligibility

What is being tested?

The study tests if monitoring skin hydration and water loss helps people stick to using Cetaphil Pro Eczema moisturizer daily. Participants will either get no extra help, answer weekly surveys, or use a device (GPSkin) that checks how well the moisturizer works.See study design

What are the potential side effects?

Since this trial involves the use of a topical moisturizer and electronic devices for monitoring, side effects are minimal but may include mild skin irritation from the product or discomfort from using the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have dry skin due to current or past eczema.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 3 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 3 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence - Moisturizer

Transepidermal water loss (TEWL) rates

Xerosis Severity

Trial Design

3Treatment groups

Experimental Treatment

Group I: GPSkin groupExperimental Treatment2 Interventions

The patients in the GPSkin group will receive the GPSkin Barrier® to measure the moisture level of their inner wrist, inner elbow, and dorsal hand daily.

Group II: Digital Interaction GroupExperimental Treatment2 Interventions

The digital interaction group will receive a survey by email each week asking about their Cetaphil use in addition to the electronic monitor measuring the adherence.

Group III: Control GroupExperimental Treatment1 Intervention

All patients will receive Cetaphil Pro Eczema moisturizer equipped with an electronic monitor to measure adherence to daily treatment of xerosis

0 / 2Eligibility criteria met